What a way to start a Saturday! #HFUpdate Great talk Drs. Connelly and Moist! One of many pearls shared: change in GFR with SGLT2i is “turning down the tap” effect, not damage- important, straightforward message for patients to support a drug with clear EARLY benefits in HF https://t.co/NPqDlduYf5
Tune in for our last plenary session of #HFUpdate with @HFSA at 2:00 pm ET on Cutting Edge Therapies where we’ll be talking about New Devices for HF, Percutaneous Valve Therapy and Challenges with “Destination Therapy” in Canada. @AniqueDucharme@MarkDraznerhttps://t.co/JMtuBauQ14